Designing a polyvalent inhibitor of anthrax toxin

Screening peptide libraries is a proven strategy for identifying inhibitors of protein–ligand interactions. Compounds identified in these screens often bind to their targets with low affinities. When the target protein is present at a high density on the surface of cells or other biological surfaces, it is sometimes possible to increase the biological activity of a weakly binding ligand by presenting multiple copies of it on the same molecule. We isolated a peptide from a phage display library that binds weakly to the heptameric cell-binding subunit of anthrax toxin and prevents the interaction between cell-binding and enzymatic moieties. A molecule consisting of multiple copies of this nonnatural peptide, covalently linked to a flexible backbone, prevented assembly of the toxin complex in vitro and blocked toxin action in an animal model. This result demonstrates that protein–protein interactions can be inhibited by a synthetic, polymeric, polyvalent inhibitor in vivo.

[1]  R. Kramer,et al.  Spanning binding sites on allosteric proteins with polymer-linked ligand dimers , 1998, Nature.

[2]  G M Whitesides,et al.  Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. , 1995, Journal of medicinal chemistry.

[3]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[4]  R. Read,et al.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.

[5]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[6]  R. Collier,et al.  Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen (*) , 1995, The Journal of Biological Chemistry.

[7]  R. Collier,et al.  Protective antigen‐binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino‐ or carboxy‐terminus , 1995, Molecular microbiology.

[8]  S. Leppla,et al.  Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. , 1993, The Journal of biological chemistry.

[9]  G. V. Vande Woude,et al.  Anthrax toxins , 1999, Cellular and Molecular Life Sciences CMLS.

[10]  R. Liddington,et al.  Crystal structure of the anthrax toxin protective antigen , 1997, Nature.

[11]  R. Collier,et al.  Identification of residues lining the anthrax protective antigen channel. , 1998, Biochemistry.

[12]  G. Whitesides,et al.  Polyacrylamides bearing pendant .alpha.-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus , 1991 .

[13]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[14]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[15]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[16]  R. Collier,et al.  Anthrax protective antigen: prepore-to-pore conversion. , 1999, Biochemistry.

[17]  G M Whitesides,et al.  A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.

[18]  N. Bovin,et al.  Synthetic polymeric sialoside inhibitors of influenza virus receptor‐binding activity , 1990, FEBS letters.

[19]  M. Zwick,et al.  Phage-displayed peptide libraries. , 1998, Current opinion in biotechnology.

[20]  R Lamb,et al.  Anthrax. , 1973, Red Book (2018).

[21]  G. Whitesides,et al.  Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions , 1996 .

[22]  J S Wall,et al.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells. , 1994, The Journal of biological chemistry.

[23]  R. Collier,et al.  Characterization of membrane translocation by anthrax protective antigen. , 1998, Biochemistry.

[24]  L. Kiessling,et al.  Synthetic ligands point to cell surface strategies , 1998, Nature.

[25]  J. Ezzell,et al.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin , 1984, Infection and immunity.